by Emily Burke, PhD | Jan 15, 2019 | Front Page Feature, Uncategorized
Fighting A Silent Epidemic Consider the liver. It’s just one of the jumble of stuff inside that makes us tick, right? What do you really know about it though—other than it’s “vital”? In fact, the liver is your largest internal organ, and plays vital roles in...
by Emily Burke, PhD | Nov 1, 2018 | Drug Development, Uncategorized
Squash That Bug The flu. Need we say more? Why yes. Yes, we do! Last week, we examined all things flu: we talked about the influenza virus structure, how the pesky pathogen makes us feel so lousy, and why the vaccine’s effectiveness isn’t always up to sniff. Er,...
by Emily Burke, PhD | Apr 12, 2018 | Commercialization, Uncategorized
The Science Behind the Deal Earlier this week, news of the $8.7 billion acquisition of gene therapy company AveXis (Bannockburn, IL) by Novartis (Basel, Switzerland) made big biotech headlines. AveXis’ lead candidate, AVXS-101, is now in Phase III clinical...
by Emily Burke, PhD | Mar 8, 2018 | Genetic Engineering, Uncategorized
MISSION IMPOSSIBLE: MEATLESS MEAT? Imagine biting into a juicy cheeseburger: the flavor, the texture, the smell. Now, imagine the cheeseburger meatless. Impossible? No. Impossible Foods, a Redwood City, CA-based company has used biotechnology to create a...
by Emily Burke, PhD | Aug 24, 2017 | Neuroscience, Uncategorized
DECODING THE GUT-BRAIN AXIS There is no shortage of microbiome-focused startups in biotech right now. The link between the gut microbiome — the entire collection of microbes living in the gut — and diseases such as inflammatory bowel disease are well-established. New...
by Emily Burke, PhD | Mar 9, 2017 | Immunology, Uncategorized
Basics & Innovations Monoclonal antibody (mAb) therapeutics burst onto the healthcare scene 20 years ago, and today they remain one of the most versatile and effective therapeutics available. The tried and true mAbs are still in high demand, and we suspect this...
